These results suggest that DS-4108b could improve fasting hypoglycemia, hepatomegaly, and major complications in GSD1a caused by G6PC c.648G>T through correction of the aberrant splicing and the G6Pase activity, especially in liver. This evidence concerns the gene G6PC1 and Hypoglycemia.